Erratum: Two engineered site-specific antibody-drug conjugates, HLmD4 and HLvM4, have potent therapeutic activity in two DLL4-positive tumour xenograft models.
American journal of cancer research（2022）
Abstract
[This corrects the article on p. 2387 in vol. 10, PMID: 32905508.].
MoreTranslated text
Key words
site-specific,antibody-drug
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined